Neuroendocrine Tumors: a Relevant Clinical Update

Area of Science:

• Neuroendocrine Oncology
• Oncology
• Neoplasms

Background:

• Neuroendocrine neoplasms (NENs) are increasingly recognized, with improved classification and epidemiological understanding.
• The field has evolved significantly since the initial description of carcinoid tumors.
• Incidence and prevalence of NENs are rising, with patients living longer.

Purpose of the Study:

• To summarize recent findings in neuroendocrine oncology.
• To highlight clinically relevant and practice-changing updates in NEN management.

Main Methods:

• Review of recent scientific literature and clinical findings.
• Analysis of advancements in NEN classification and epidemiology.
• Evaluation of new therapeutic strategies and molecular insights.

Main Results:

• Neuroendocrine tumors (NETs) have largely replaced the term carcinoid tumor.
• Significant progress in understanding molecular drivers of tumorigenesis.
• Multiple new drug approvals for advanced NEN treatment.
• Evolving clarity on the utility of NET biomarkers.

Conclusions:

• Continued increase in NEN incidence and prevalence necessitates updated management strategies.
• Enhanced understanding of molecular drivers and immunotherapy holds promise for transforming NEN care.
• Ongoing research is crucial for further elevating the standard of care for NEN patients.